Free Trial
NYSEARCA:IHE

iShares U.S. Pharmaceuticals ETF (IHE) Price, Holdings, & News

iShares U.S. Pharmaceuticals ETF logo
$70.70 -0.34 (-0.47%)
As of 03:37 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Key Stats

Today's Range
$70.54
$71.05
50-Day Range
$64.77
$71.04
52-Week Range
$58.97
$73.28
Volume
27,426 shs
Average Volume
77,035 shs
Market Capitalization
$579.78 million
Assets Under Management
$579.26 million
Dividend Yield
1.64%
Net Expense Ratio
0.39%
Aggregate Rating
Moderate Buy

ETF Overview

iShares U.S. Pharmaceuticals ETF Expenses

TypeIHEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.39%0.56%0.56%0.51%0.53%
Other Expenses0.00%0.47%0.56%0.59%0.56%
Total Expense0.39%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.71%-0.63%
Net Expense0.39%0.60%0.63%0.58%0.60%
Receive IHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IHE ETF News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
IHE: Healthcare Dashboard For June
See More Headlines

IHE ETF - Frequently Asked Questions

iShares U.S. Pharmaceuticals ETF's stock was trading at $65.72 at the beginning of the year. Since then, IHE shares have increased by 7.6% and is now trading at $70.7050.

Shares of iShares U.S. Pharmaceuticals ETF split on Thursday, March 7th 2024.The 3-1 split was announced on Thursday, March 7th 2024. The newly minted shares were distributed to shareholders after the market closes on Thursday, March 7th 2024. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

iShares U.S. Pharmaceuticals ETF's top institutional investors include Fisher Asset Management LLC (36.30%), BNP Paribas Financial Markets (2.44%), Bank of America Corp DE (1.48%) and JPMorgan Chase & Co. (1.35%).

Shares of IHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares U.S. Pharmaceuticals ETF investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), Visa (V), Adobe (ADBE), Lam Research (LRCX) and Advanced Micro Devices (AMD).

Fund Details

Issuer
iShares
Fund Name
iShares U.S. Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IHE
Inception Date
5/1/2006
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Dow Jones U.S. Select Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
40

Fund Statistics

Assets Under Management
$579.26 million
Average Daily Volume
$36.44 thousand
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
Citibank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
Citibank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
3
Put Options
69
Call Options
3
Short Interest
427,600 shs

Miscellaneous

Beta
0.70
Creation Unit
50,000
Creation Fee
$306.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Top 10 IHE Holdings

IHE Sector Exposure

IHE Industry Exposure


This page (NYSEARCA:IHE) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners